Issue 5/2010
Content (28 Articles)
Alpha particles more promising than toxins?
Jacques Barbet, Michel Chérel, Jean-François Chatal
In vitro experimental 211At-anti-CD33 antibody therapy of leukaemia cells overcomes cellular resistance seen in vivo against gemtuzumab ozogamicin
Thorsten Petrich, Zekiye Korkmaz, Doris Krull, Cornelia Frömke, Geerd J. Meyer, Wolfram H. Knapp
A theoretical dose-escalation study based on biological effective dose in radioimmunotherapy with 90Y-ibritumomab tiuxetan (Zevalin)
Massimiliano Pacilio, Margherita Betti, Francesco Cicone, Carolina Del Mastro, Livia Montani, Laura Chiacchiararelli, Alessia Monaco, Enrico Santini, Francesco Scopinaro
Biodistribution and radiation dosimetry of [11C]choline: a comparison between rat and human data
Tuula Tolvanen, Timo Yli-Kerttula, Tiina Ujula, Anu Autio, Pertti Lehikoinen, Heikki Minn, Anne Roivainen
Pre-therapeutic 124I PET(/CT) dosimetry confirms low average absorbed doses per administered 131I activity to the salivary glands in radioiodine therapy of differentiated thyroid cancer
Walter Jentzen, Robert F. Hobbs, Alexander Stahl, Jochen Knust, George Sgouros, Andreas Bockisch
Dosimetry-guided high-activity 131I therapy in patients with advanced differentiated thyroid carcinoma: initial experience
Frederik A. Verburg, Heribert Hänscheid, Johannes Biko, Maria C. Hategan, Michael Lassmann, Michael C. Kreissl, Christoph Reiners, Markus Luster
Efficacy of using a standard activity of 131I-MIBG therapy in patients with disseminated neuroendocrine tumours
Shaunak Navalkissoor, Dona M. Alhashimi, Ann-Marie Quigley, Martyn E. Caplin, John R. Buscombe
The new FDG brain revolution: the neurovascular unit and the default network
Stelvio Sestini, Antonio Castagnoli, Luigi Mansi
Approaches to quantify radioligands that wash out slowly from target organs
Jussi Hirvonen, Garth E. Terry, Christer Halldin, Victor W. Pike, Robert B. Innis
Kinetic analysis of the cannabinoid-1 receptor PET tracer [18F]MK-9470 in human brain
Sandra Marina Sanabria-Bohórquez, Terence G. Hamill, Karolien Goffin, Inge De Lepeleire, Guy Bormans, H. Donald Burns, Koen Van Laere
In vivo detection of prion amyloid plaques using [11C]BF-227 PET
Nobuyuki Okamura, Yusei Shiga, Shozo Furumoto, Manabu Tashiro, Yoshio Tsuboi, Katsutoshi Furukawa, Kazuhiko Yanai, Ren Iwata, Hiroyuki Arai, Yukitsuka Kudo, Yasuhito Itoyama, Katsumi Doh-ura
Dose-response assessment of tariquidar and elacridar and regional quantification of P-glycoprotein inhibition at the rat blood-brain barrier using (R)-[11C]verapamil PET
Claudia Kuntner, Jens P. Bankstahl, Marion Bankstahl, Johann Stanek, Thomas Wanek, Gloria Stundner, Rudolf Karch, Rebecca Brauner, Martin Meier, Xiaoqi Ding, Markus Müller, Wolfgang Löscher, Oliver Langer
Protective effects of repetitive transcranial magnetic stimulation in a rat model of transient cerebral ischaemia: a microPET study
Feng Gao, Shuang Wang, Yi Guo, Jing Wang, Min Lou, Jimin Wu, Meiping Ding, Mei Tian, Hong Zhang
In vivo imaging of neuroinflammation: a comparative study between [18F]PBR111, [11C]CLINME and [11C]PK11195 in an acute rodent model
Nadja Van Camp, Raphael Boisgard, Bertrand Kuhnast, Benoit Thézé, Thomas Viel, Marie-Claude Grégoire, Fabien Chauveau, Hervé Boutin, Andrew Katsifis, Frédéric Dollé, Bertrand Tavitian
Hybrid versus fusion imaging: are we moving forward judiciously?
Luca Giovanella, Giovanni Lucignani
Integrating imaging modalities: what makes sense from a workflow perspective?
Gustav K. von Schulthess, Cyrill Burger
High throughput static and dynamic small animal imaging using clinical PET/CT: potential preclinical applications
Nicolas Aide, Cédric Desmonts, Jean-Mathieu Beauregard, Thomas Beyer, Kathryn Kinross, Peter Roselt, Oliver Neels, Denis Agostini, Stéphane Bardet, Gérard Bouvard, Rodney J. Hicks
Use of 99mTc-MDP SPECT for assessment of mandibular growth: development of normal values
Frederic H. Fahey, Zachary R. Abramson, Bonnie L. Padwa, Robert E. Zimmerman, David Zurakowski, Mark Nissenbaum, Leonard B. Kaban, S. Ted Treves
Clearance of the high intestinal 18F-FDG uptake associated with metformin after stopping the drug
Tamer Özülker, Filiz Özülker, Meral Mert, Tevfik Özpaçacı
Kidney protection during peptide receptor radionuclide therapy with somatostatin analogues
Edgar J. Rolleman, Marleen Melis, Roelf Valkema, Otto C. Boerman, Eric P. Krenning, Marion de Jong
Doctor, what does my future hold? The prognostic value of FDG-PET in solid tumours
Giovanni Lucignani, Steven M. Larson
Can an undetectable value of TG and a negative neck ultrasound study be considered reliable methods to assess the completeness of thyroid ablation?
Massimo Salvatori, Germano Perotti, Luca Giovanella, Massimo Eugenio Dottorini
Reply to: Can an undetectable value of TG and a negative neck ultrasound study be considered reliable methods to assess the completeness of thyroid ablation?
Glenn D. Flux, Masud Haq, Sarah J. Chittenden, Susan Buckley, Cecilia Hindorf, Kate Newbold, Clive L. Harmer
Torsten B. Moeller and Emil Reif (eds). 2009. Pocket atlas of radiographic positioning
Luigi Mansi
Erratum to: Kinetic analysis of the cannabinoid-1 receptor PET tracer [18F]MK-9470 in human brain
Sandra Marina Sanabria-Bohórquez, Terence G. Hamill, Karolien Goffin, Inge De Lepeleire, Guy Bormans, H. Donald Burns, Koen Van Laere
High-resolution 18F-FDG PET with MRI for monitoring response to treatment in rheumatoid arthritis
Abhijit J. Chaudhari, Spencer L. Bowen, George W. Burkett, Nathan J. Packard, Felipe Godinez, Anand A. Joshi, Stanley M. Naguwa, David K. Shelton, John C. Hunter, John M. Boone, Michael H. Buonocore, Ramsey D. Badawi
Extrastriatal uptake on 123I-ioflupane brain SPECT
Gaetane Ceulemans, Douwe Verdries, Jan Versijpt, Christian Vanhove, Hendrik Everaert
Guidance on current good radiopharmacy practice (cGRPP) for the small-scale preparation of radiopharmaceuticals
Philip Elsinga, Sergio Todde, Ivan Penuelas, Geerd Meyer, Brit Farstad, Alain Faivre-Chauvet, Renata Mikolajczak, Gerrit Westera, Tanja Gmeiner-Stopar, Clemens Decristoforo